Vilin Bio Med Limited (NSE:VILINBIO)
India · Delayed Price · Currency is INR 28.90
+1.35 (4.90%)
Jan 23, 2026, 3:21 PM IST
Vilin Bio Med Revenue
Vilin Bio Med had revenue of 96.64M INR in the half year ending September 30, 2025, with 24.64% growth. This brings the company's revenue in the last twelve months to 199.81M, up 52.70% year-over-year. In the fiscal year ending March 31, 2025, Vilin Bio Med had annual revenue of 148.10M, down -6.30%.
Revenue (ttm)
199.81M
Revenue Growth
+52.70%
P/S Ratio
2.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
403.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 148.10M | -9.95M | -6.30% |
| Mar 31, 2024 | 158.05M | 34.68M | 28.11% |
| Mar 31, 2023 | 123.37M | 11.18M | 9.97% |
| Mar 31, 2022 | 112.19M | -5.00M | -4.26% |
| Mar 31, 2021 | 117.19M | -51.05M | -30.35% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 922.09M |
| Deccan Health Care | 847.12M |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Gujarat Terce Laboratories | 501.95M |
| Panjon | 463.51M |